Head-To-Head Review: ResMed (RMD) vs. Alliance HealthCare Services (AIQ)

ResMed (NYSE: RMD) and Alliance HealthCare Services (NASDAQ:AIQ) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk and valuation.

Risk & Volatility

ResMed has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500. Comparatively, Alliance HealthCare Services has a beta of 0.66, meaning that its share price is 34% less volatile than the S&P 500.

Valuation and Earnings

This table compares ResMed and Alliance HealthCare Services’ top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
ResMed $2.07 billion 5.26 $568.89 million $2.41 31.76
Alliance HealthCare Services N/A N/A N/A ($0.17) -76.47

ResMed has higher revenue and earnings than Alliance HealthCare Services. Alliance HealthCare Services is trading at a lower price-to-earnings ratio than ResMed, indicating that it is currently the more affordable of the two stocks.

Dividends

ResMed pays an annual dividend of $1.40 per share and has a dividend yield of 1.8%. Alliance HealthCare Services does not pay a dividend. ResMed pays out 58.1% of its earnings in the form of a dividend.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for ResMed and Alliance HealthCare Services, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ResMed 3 5 2 0 1.90
Alliance HealthCare Services 0 0 0 0 N/A

ResMed presently has a consensus price target of $64.80, indicating a potential downside of 15.35%. Given ResMed’s higher probable upside, research analysts clearly believe ResMed is more favorable than Alliance HealthCare Services.

Insider & Institutional Ownership

60.1% of ResMed shares are owned by institutional investors. Comparatively, 27.0% of Alliance HealthCare Services shares are owned by institutional investors. 1.8% of ResMed shares are owned by insiders. Comparatively, 54.8% of Alliance HealthCare Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares ResMed and Alliance HealthCare Services’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ResMed 16.56% 21.99% 11.86%
Alliance HealthCare Services 3.63% N/A 3.07%

Summary

ResMed beats Alliance HealthCare Services on 10 of the 12 factors compared between the two stocks.

ResMed Company Profile

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company’s portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions. The Company produces Continuous Positive Airway Pressure (CPAP), Variable Positive Airway Pressure (VPAP) and AutoSet systems for the titration and treatment of SDB.

Alliance HealthCare Services Company Profile

Alliance HealthCare Services, Inc. (Alliance) is a provider of outsourced healthcare services to hospitals and providers. The Company operates through three segments: Radiology Division, Oncology Division and Interventional Healthcare Services Division. The radiology segment comprises diagnostic imaging services, including magnetic resonance imaging (MRI), positron emission tomography/computed tomography (PET/CT) and other imaging services. The radiology segment also comprises radiation oncology services. The interventional healthcare services segment provides interventional healthcare through therapeutic minimally invasive pain management procedures medical management, laboratory testing and other services. The Company operates freestanding outpatient radiology, oncology and interventional clinics, and Ambulatory Surgical Centers (ASC) that are not owned by hospitals or providers. It operates over 560 diagnostic imaging and radiation therapy systems.

Receive News & Ratings for ResMed Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ResMed Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply